(E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine
C15H27N3O — CID 143680515
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine
(E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine (PubChem CID 143680515) has the molecular formula C15H27N3O and a molecular weight of 265.40 g/mol. Its IUPAC name is (E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine.
Molecular Properties
| Compound Name | (E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine |
|---|---|
| PubChem CID | 143680515 |
| Molecular Formula | C15H27N3O |
| Molecular Weight | 265.40 g/mol |
| Exact Mass | 265.22 |
| IUPAC Name | (E,3Z)-2-[3-(ethylamino)propoxy]-3-(4-propyl-1,2-dihydropyrrol-3-ylidene)prop-1-en-1-amine |
| SMILES | CCCC1=CNC/C1=C\C(=C/N)OCCCNCC |
| InChI | InChI=1S/C15H27N3O/c1-3-6-13-11-18-12-14(13)9-15(10-16)19-8-5-7-17-4-2/h9-11,17-18H,3-8,12,16H2,1-2H3/b14-9+,15-10+ |
| InChIKey | SKRZRRNCCQNTOK-AOEKMSOUSA-N |
| XLogP | 2.02 |
| TPSA | 59.31 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 265.40 |
| LogP ≤ 5 | 2.02 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143680515 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.